Vlietstra R E, McGoon M D
Postgrad Med. 1984 Sep 1;76(3):71-3, 76-7, 80. doi: 10.1080/00325481.1984.11698714.
The six currently available beta-adrenergic blocking agents have significant and clinically important differences in their potency, selectivity, partial agonist effect, lipid solubility, and cost. These differences account for many of the observed variations in drug action and dosage scheduling as well as for some of the side effects. Careful choices within this group may lead to more effective treatment.
目前可用的六种β-肾上腺素能阻滞剂在效力、选择性、部分激动剂效应、脂溶性和成本方面存在显著且具有临床重要意义的差异。这些差异解释了所观察到的药物作用和剂量安排的许多变化以及一些副作用。在这一组药物中进行仔细选择可能会带来更有效的治疗。